Home LiteratureArticle Details
PMID: 12242304 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.

Molecular and cellular biology ·Vol. 22 ·No. 20 ·2002-10-00 ·Pages 7291-301

González-Suárez E, Flores JM, Blasco MA

Abstract

Telomerase reintroduction in adult somatic tissues is envisioned as a way to extend their proliferative capacity. It is still a question, however, whether constitutive telomerase expression in adult tissues impacts the normal aging and spontaneous cancer incidence of an organism. Here, we studied the aging and spontaneous cancer incidence of mice with transgenic telomerase expression in a wide range of adult tissues, K5-Tert mice. For this, we maintained large colonies of K5-Tert mice for more than 2 years. K5-Tert mice showed a decreased life span compared to wild-type cohorts associated with a higher incidence of preneoplastic and neoplastic lesions in various tissue types. Neoplasias in K5-Tert mice were coincident with transgene expression in the affected tissues. These observations suggest that high telomerase activity may cooperate with genetic alterations that occur with age to promote tumorigenesis. Indeed, we demonstrate here that increased cancer incidence and the reduced viability of K5-Tert mice are aggravated in a p53(+/-) genetic background, indicating that telomerase cooperates with loss of p53 function in inducing tumorigenesis. Altogether, these results demonstrate that constitutive high levels of telomerase activity result in a decreased life span associated with an increased incidence of neoplasias as the organism ages.

MeSH Terms
Animals DNA-Binding Proteins Data Interpretation, Statistical Gene Expression Incidence Lymphoid Tissue Mice Mice, Knockout Mice, Transgenic Mutagenesis Neoplasms/pathology Precancerous Conditions/pathology Telomerase/genetics,metabolism Tumor Suppressor Protein p53/genetics,metabolism
Chemicals
DNA-Binding Proteins Tumor Suppressor Protein p53 Telomerase Tert protein, mouse
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
González-Suárez Eva
Department of Immunology and Oncology, National Center for Biotechnology, E-28049 Madrid, Spain.
Flores Juana M
Blasco María A
References (33)
33 references, click to expand
  1. A telomerase component is defective in the human disease dyskeratosis congenita.
    Nature. 1999 Dec 2;402(6761):551-5 PMID: 10591218
  2. Creation of human tumour cells with defined genetic elements.
    Nature. 1999 Jul 29;400(6743):464-8 PMID: 10440377
  3. Mammalian telomeres and telomerase.
    Curr Opin Cell Biol. 2000 Jun;12(3):378-83 PMID: 10801465
  4. Risky immortalization by telomerase.
    Nature. 2000 Jun 15;405(6788):755-6 PMID: 10866187
  5. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.
    Nat Genet. 2000 Sep;26(1):114-7 PMID: 10973262
  6. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective.
    Mech Ageing Dev. 2001 May 31;122(7):659-71 PMID: 11322991
  7. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
    Nat Genet. 2001 Jun;28(2):155-9 PMID: 11381263
  8. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.
    EMBO J. 2001 Jun 1;20(11):2619-30 PMID: 11387197
  9. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10308-13 PMID: 11517337
  10. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres.
    EMBO Rep. 2001 Sep;2(9):800-7 PMID: 11520856
  11. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability.
    Cell. 2001 Oct 5;107(1):67-77 PMID: 11595186
  12. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
    Oncogene. 2002 Jan 21;21(4):553-63 PMID: 11850780
  13. Many ways to telomere dysfunction: in vivo studies using mouse models.
    Oncogene. 2002 Jan 21;21(4):584-91 PMID: 11850783
  14. Telomeres shorten during ageing of human fibroblasts.
    Nature. 1990 May 31;345(6274):458-60 PMID: 2342578
  15. Structure and function of telomeres.
    Nature. 1991 Apr 18;350(6319):569-73 PMID: 1708110
  16. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  17. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
    Nat Genet. 1993 Nov;5(3):225-9 PMID: 8275085
  18. Tumor spectrum analysis in p53-mutant mice.
    Curr Biol. 1994 Jan 1;4(1):1-7 PMID: 7922305
  19. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
    EMBO J. 1995 Nov 1;14(21):5216-23 PMID: 7489711
  20. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.
    Nat Genet. 1996 Feb;12(2):200-4 PMID: 8563761
  21. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
    Mol Cell Biol. 1996 Jul;16(7):3765-72 PMID: 8668193
  22. A survey of telomerase activity in human cancer.
    Eur J Cancer. 1997 Apr;33(5):787-91 PMID: 9282118
  23. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.
    Cell. 1997 Oct 3;91(1):25-34 PMID: 9335332
  24. Telomerase and cell proliferation in mouse skin papillomas.
    Mol Carcinog. 1997 Dec;20(4):329-31 PMID: 9433476
  25. Extension of life-span by introduction of telomerase into normal human cells.
    Science. 1998 Jan 16;279(5349):349-52 PMID: 9454332
  26. Essential role of mouse telomerase in highly proliferative organs.
    Nature. 1998 Apr 9;392(6676):569-74 PMID: 9560153
  27. The telomerase reverse transcriptase: components and regulation.
    Genes Dev. 1998 Apr 15;12(8):1073-85 PMID: 9553037
  28. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype.
    Nat Genet. 1999 Jan;21(1):111-4 PMID: 9916802
  29. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
    Nat Genet. 1999 Jan;21(1):115-8 PMID: 9916803
  30. Longevity, stress response, and cancer in aging telomerase-deficient mice.
    Cell. 1999 Mar 5;96(5):701-12 PMID: 10089885
  31. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse.
    Cell. 1999 May 14;97(4):515-25 PMID: 10338215
  32. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.
    Cell. 1999 May 14;97(4):527-38 PMID: 10338216
  33. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts.
    Nat Genet. 2000 Jan;24(1):16-7 PMID: 10615119
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2002-10-00
Pages
7291-301
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC139804
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com